As the Utah Senate is considering legalizing marijuana for medical usage this week, they heard testimony from DEA Special Agent Matt Fairbanks. Agent Matt is definitely “special”, I’ll say that.

A study published in November 2014 in Molecular Cancer Therapeutics and conducted at St. George’s University of London’s Department of Oncology has found that the use of cannabinoids, specifically delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), may be useful in treating high-grade gliomas, potentially slowing the disease’s progression. Some of the results from this study, summarized by MedicalJane.com:

According to a recent article from the Pew Research Center, attitudes about marijuana have undergone a rapid shift in public opinion, paralleled by few other trends in the U.S. Their recent data, along with historical figures from Gallup and the General Social Survey, reveal how views have shifted about the drug

This impressive list is a collection of clinical studies, papers and reference providing the ultimate resource for medical disorders helped by medical marijuana.  For those who are looking for scientific proof of cannabis as medicine, this is a gold mine of research, many right from the government’s own website. And bear

This is a most excellent dissertation, filled with relevant facts documenting the historical uses of cannabis as medicine and the unreasonable position stubbornly held by the DEA. On August 16, 2005, Dr. Lester Grinspoon M.D., Harvard Medical School Emeritus prepared a statement for the DEA regarding the history of cannabis as a

Nearly 30 million people, or nearly 10% of the population in the U.S. are currently diagnosed with diabetes, making it one of the most significant health issues of our time.  It is a deadly disease which ultimately kills it’s victims, either directly or from associated complications.  Researchers searching for solutions